Adrenergic Pathology
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use (NCT01912040) | Nova Scotia Health Authority | 2006-07-01 |
Track Adrenergic Pathology automatically
Every clearance here is in the API, with alerts when new ones post.